Influence of sex on the survival of patients with esophageal cancer

Journal of Clinical Oncology

Volumn 30, Issue 18, 2012, Pages 2265-2272

  Bohanes, Pierre ^a   Yang, Dongyun ^a   Chhibar, Ruchika S ^a   Labonte, Melissa J ^a   Winder, Thomas ^a   Ning, Yan ^a   Gerger, Armin ^a   Benhaim, Léonor ^a   Paez, David ^a   Wakatsuki, Takeru ^a   Loupakis, Fotios ^a   El Khoueiry, Rita ^a   Zhang, Wu ^a   Lenz, Heinz Josef ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGE; AGED; ARTICLE; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS METASTASIS; ETHNICITY; FEMALE; HISTOLOGY; HUMAN; LOCOREGIONAL ESOPHAGUS CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84864011847     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.38.8751     Document Type: Article

References (50)

1. Ferlay J, Shin HR, Bray F, et al: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917, 2010
2. Jemal A, Siegel R, Xu J, et al: Cancer Statistics, 2010. CA Cancer J Clin 60:277-300, 2010
3. Schreiber D, Rineer J, Vongtama D, et al: Impact of postoperative radiation after esophagectomy for esophageal cancer. J Thorac Oncol 5:244-250, 2010
4. Salek R, Bezenjani SE, Saedi HS, et al: A geographic area with better outcome of esophageal carcinoma: Is there an effect of ethnicity and etiologic factors? Oncology 77:172-177, 2009
5. Schwer AL, Ballonoff A, McCammon R, et al: Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: A Surveillance, Epidemiology, and End Results study. Int J Radiat Oncol Biol Phys 73:449-455, 2009
6. Paulson EC, Ra J, Armstrong K, et al: Underuse of esophagectomy as treatment for resectable esophageal cancer. Arch Surg 143:1198-1203, 2008
7. Morita M, Yoshida R, Ikeda K, et al: Advances in esophageal cancer surgery in Japan: An analysis of 1000 consecutive patients treated at a single institute. Surgery 143:499-508, 2008
8. Badwe RA, Patil PK, Bhansali MS, et al: Impact of age and sex on survival after curative resection for carcinoma of the esophagus. Cancer 74:2425-2429, 1994 (Pubitemid 24320843)
9. Sugimachi K, Matsuoka H, Matsufuji H, et al: Survival rates of women with carcinoma of the esophagus exceed those of men. Surg Gynecol Obstet 164:541-544, 1987 (Pubitemid 17091223)
10. Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137-2150, 2006 (Pubitemid 46655601)
11. Howlader N, Noone AM, Krapcho M, et al (eds): SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. http://seer.cancer. gov/csr/1975-2008/
12. Wang QM, Qi YJ, Jiang Q, et al: Relevance of serum estradiol and estrogen receptor beta expression from a high-incidence area for esophageal squamous cell carcinoma in China. Med Oncol 28:188-193, 2011
13. Derakhshan MH, Liptrot S, Paul J, et al: Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females. Gut 58:16-23, 2009
14. Marmo R, Rotondano G, Piscopo R, et al: Combination of age and sex improves the ability to predict upper gastrointestinal malignancy in patients with uncomplicated dyspepsia: A prospective multicentre database study. Am J Gastroenterol 100:784-791, 2005 (Pubitemid 40592366)
15. Hendifar A, Yang D, Lenz F, et al: Gender disparities in metastatic colorectal cancer survival. Clin Cancer Res 15:6391-6397, 2009
16. National Cancer Institute: Surveillance, Epidemiology, and End Results, Overview of the SEER program. http://seer.cancer.gov/about/overview.html
17. Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496-509, 1999
18. Rothman KJ: No adjustments are needed for multiple comparisons. Epidemiology 1:43-46, 1990
19. Engel LS, Chow WH, Vaughan TL, et al: Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95:1404-1413, 2003 (Pubitemid 37220460)
20. Corley DA, Kubo A, Levin TR, et al: Helicobacter pylori infection and the risk of Barrett's oesophagus: A community-based study. Gut 57:727-733, 2008 (Pubitemid 351716961)
21. Pohl H, Welch HG: The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97:142-146, 2005 (Pubitemid 40277094)
22. Brown LM, Devesa SS, Chow WH: Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 100:1184-1187, 2008
23. Wang BY, Goan YG, Hsu PK, et al: Tumor length as a prognostic factor in esophageal squamous cell carcinoma. Ann Thorac Surg 91:887-893, 2011
24. Tong DK, Law S, Kwong DL, et al: Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol 17:2184-2192, 2010
25. McKinlay SM, Brambilla DJ, Posner JG: The normal menopause transition. Maturitas 14:103-115, 1992
26. Ueo H, Matsuoka H, Sugimachi K, et al: Inhibitory effects of estrogen on the growth of a human esophageal carcinoma cell line. Cancer Res 50:7212-7215, 1990
27. Matsuoka H, Sugimachi K, Ueo H, et al: Sex hormone response of a newly established squamous cell line derived from clinical esophageal carcinoma. Cancer Res 47:4134-4140, 1987 (Pubitemid 17108483)
28. Utsumi Y, Nakamura T, Nagasue N, et al: Role of estrogen receptors in the growth of human esophageal carcinoma. Cancer 64:88-93, 1989 (Pubitemid 19167142)
29. Kalayarasan R, Ananthakrishnan N, Kate V, et al: Estrogen and progesterone receptors in esophageal carcinoma. Dis Esophagus 21:298-303, 2008 (Pubitemid 351663444)
30. Hartman J, Ström A, Gustafsson JA: Estrogen receptor beta in breast cancer: Diagnostic and therapeutic implications. Steroids 74:635-641, 2009
31. Nozoe T, Oyama T, Takenoyama M, et al: Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus. Clin Cancer Res 13: 4046-4050, 2007 (Pubitemid 47105964)
32. Yamashita Y, Hirai T, Mukaida H, et al: Detection of androgen receptors in human esophageal cancer. Jpn J Surg 19:195-202, 1989 (Pubitemid 19133380)
33. Malik SM, Nevin DT, Cohen S, et al: Assessment of immunohistochemistry for p16INK4 and high-risk HPV DNA by in situ hybridization in esophageal squamous cell carcinoma. Int J Surg Pathol 19:31-34, 2011
34. Syrjänen KJ: HPV infections and oesophageal cancer. J Clin Pathol 55:721-728, 2002
35. Tribius S, Ihloff AS, Rieckmann T, et al: Impact of HPV status on treatment of squamous cell cancer of the oropharynx: What we know and what we need to know. Cancer Lett 304:71-79, 2011
36. Antonsson A, Nancarrow DJ, Brown IS, et al: High-risk human papillomavirus in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 19:2080-2087, 2010
37. Dreilich M, Bergqvist M, Moberg M, et al: High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: A pilot study. BMC Cancer 6:94, 2006
38. Solomon N, Zhuge Y, Cheung M, et al: The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma. Ann Surg Oncol 17:791-803, 2010
39. Akgun H, Lechago J, Younes M: Estrogen receptor-beta is expressed in Barrett's metaplasia and associated adenocarcinoma of the esophagus. Anticancer Res 22:1459-1461, 2002
40. Tihan T, Harmon JW, Wan X, et al: Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus. Anticancer Res 21:3107-3114, 2001 (Pubitemid 33051184)
41. van Soest EM, Siersema PD, Dieleman JP, et al: Age and sex distribution of the incidence of Barrett's esophagus found in a Dutch primary care population. Am J Gastroenterol 100:2599-2600, 2005
42. van Blankenstein M, Looman CW, Johnston BJ, et al: Age and sex distribution of the prevalence of Barrett's esophagus found in a primary referral endoscopy center. Am J Gastroenterol 100:568-576, 2005 (Pubitemid 40487554)
43. Walsh TN, Noonan N, Hollywood D, et al: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462-467, 1996 (Pubitemid 26269945)
44. Advani SH, Saikia TK, Swaroop S, et al: Anterior chemotherapy in esophageal cancer. Cancer 56:1502-1506, 1985 (Pubitemid 15228490)
45. Ezdinli EZ, Gelber R, Desai DV, et al: Chemotherapy of advanced esophageal carcinoma: Eastern Cooperative Oncology Group experience. Cancer 46:2149-2153, 1980 (Pubitemid 11240577)
46. Wang L, Wilson SE, Stewart DB, et al: Marital status and colon cancer outcomes in US Surveillance, Epidemiology and End Results registries: Does marriage affect cancer survival by gender and stage? Cancer Epidemiol 35:417-422, 2011
47. Souza RF, Spechler SJ: Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach. CA Cancer J Clin 55:334-351, 2005 (Pubitemid 41677376)
48. Gebski V, Burmeister B, Smithers BM, et al: Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis. Lancet Oncol 8:226-234, 2007 (Pubitemid 46291702)
49. Rebecca WO, Richard MA: Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev 1:CD002092, 2003
50. Hongo M, Nagasaki Y, Shoji T: Epidemiology of esophageal cancer: Orient to Occident - Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 24:729-735, 2009